GleanMark

INVIZYNE Trademark

INVIZYNE is a USPTO trademark filed by Invizyne Technologies, Inc.. Status: Pending.

Trademark Facts

MarkINVIZYNE
Serial Number90287671
StatusPending
Filing Date2020-10-29
Mark TypeCombined
Nice Classes003 (Cosmetics), 004 (Lubricants & Fuels), 005 (Pharmaceuticals), 030 (Staple Foods)
OwnerInvizyne Technologies, Inc.
Attorney of RecordThomas C. Lundin Jr.
Prosecution Events43
Latest EventGNRN on 2026-03-18

Goods & Services

Fragrances; terpenes for use in essential oils | Biofuels; fuels, biofuels and biodiesels based on energy-producing organic compounds, namely, terpenes, isoprenoids, alcohols, fatty acids, esters, alkanes, and alkenes | Pharmaceuticals, namely, alcohols, esters, alkaloids, polyketides, steroids, isoprenoids, and non-ribosomal peptides, for use the treatment of pain, neuropathic pain, cancer pain, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, multiple sclerosis, spinal cord injury, bladder disfunction, peripheral neuropathy, spasticity, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, essential tremors, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, post-traumatic stress disorder, obesity, obesity associated with Type II Diabetes, bulimia, schizophrenia, Crohn's disease, Alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse, epilepsy, convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome, chromosome disorders, and metabolic disorders; anti-inflammatories; analgesics; nutraceuticals for use as a dietary supplement; dietary and nutritional supplements; none of the foregoing containing CBD, cannabinoids or tryptamines | Flavor enhancers for use in food and beverage products

Recent Prosecution Activity

DateDocumentType
2026-03-18Notice of Non-Final Office ActionNFO
2026-03-18Non-Final ActionNFIN
2023-09-06ITU Unit ActionIUA
2023-08-24Statement of UseSOU
2023-08-24SpecimenSPE
2023-08-23Change Address or Representation FormCAR

USPTO Refusals on Record

Related